Orexigen Therapeutic
OREX
Delayed Nasdaq - 01/18 09:59:59 pm
1.16USD
-0.85%
Upcoming events

- No events available -

Past Events
11/13/17 | 11:00pmQ3 2017 Earnings Call
11/13/17 | 10:01pmQ3 2017 Earnings Release
10/17/17 | 06:15pmBIO Investor Forum
09/27/17 | 10:35pmCantor Fitzgerald Global Healthcare Conference
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread
33,7
33,4
0,90%

85,9
Operating income (EBITDA)
Million $
Released
Forecast
Spread
-130
-138
5,5%

-135
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-131
-96,3
-36%

-144
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-24,5
-45,3
46%

-147
EPS
 $
Released
Forecast
Spread
-1,68
-2,69
38%

-10,1
Announcement Date03/28/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread
18,9
24,2
-22%

25,0
Operating income (EBITDA)
 
Released
Forecast
Spread




Operating profit (EBIT)
 
Released
Forecast
Spread




Pre-Tax Profit (EBT)
 
Released
Forecast
Spread




Net income
Million $
Released
Forecast
Spread
-20,8



EPS
 $
Released
Forecast
Spread
-1,35


-2,06
Announcement Date11/13/2017
Net sales - Rate of surprise
Operating profit - Rate of surprise
EPS - Rate of surprise